Zaccardelli David insider trades
Zaccardelli David has filed 42 Form 4s with the SEC that we hold, for VRNA (President and CEO, Director), SAB Biotherapeutics, Inc. (SABS) (Director) and Vor Biopharma Inc. (VOR) (Director). Across all of them we count 0 purchases worth $0 and 46 sales worth $35.2M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 400,000 shares of VRNA worth $4.6M, dated 2025-06-11. The first filing on our record is dated 2021-08-04 and the latest 2026-07-09.
VRNA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-03 | S, sale reported on Form 4 | 17,656 | $13.2K | 2021-08-09 |
| 2021-08-03 | S, sale reported on Form 4 | 16,000 | $12.2K | 2021-08-04 |
| 2021-08-04 | S, sale reported on Form 4 | 18,400 | $13.6K | 2021-08-04 |
| 2021-11-02 | S, sale reported on Form 4 | 52,056 | $33.3K | 2021-11-03 |
| 2022-02-03 | S, sale reported on Form 4 | 52,056 | $38.0K | 2022-02-03 |
| 2022-05-03 | S, sale reported on Form 4 | 32,904 | $16.5K | 2022-05-05 |
| 2022-08-01 | S, sale reported on Form 4 | 32,904 | $23.0K | 2022-08-03 |
| 2022-08-09 | S, sale reported on Form 4 | 600,000 | $1.1M | 2022-08-11 |
| 2022-11-01 | S, sale reported on Form 4 | 32,904 | $54.9K | 2022-11-03 |
| 2022-12-20 | S, sale reported on Form 4 | 600,000 | $1.3M | 2022-12-21 |
| 2023-02-01 | S, sale reported on Form 4 | 432,928 | $1.1M | 2023-02-03 |
| 2023-05-01 | S, sale reported on Form 4 | 455,536 | $1.2M | 2023-05-03 |
| 2023-08-01 | S, sale reported on Form 4 | 105,944 | $283.9K | 2023-08-03 |
| 2023-08-02 | S, sale reported on Form 4 | 73,704 | $190.9K | 2023-08-03 |
| 2023-08-03 | S, sale reported on Form 4 | 117,272 | $297.9K | 2023-08-07 |
| 2023-08-04 | S, sale reported on Form 4 | 150,000 | $375.0K | 2023-08-07 |
| 2023-08-07 | S, sale reported on Form 4 | 8,616 | $21.3K | 2023-08-07 |
| 2024-08-12 | S, sale reported on Form 4 | 1,600 | $5.0K | 2024-08-14 |
| 2024-08-13 | S, sale reported on Form 4 | 390,184 | $1.2M | 2024-08-14 |
| 2024-08-13 | S, sale reported on Form 4 | 8,216 | $26.7K | 2024-08-14 |
| 2024-09-11 | S, sale reported on Form 4 | 600,000 | $2.3M | 2024-09-13 |
| 2024-10-18 | S, sale reported on Form 4 | 245,784 | $1.1M | 2024-10-22 |
| 2024-10-21 | S, sale reported on Form 4 | 110,456 | $483.8K | 2024-10-22 |
| 2024-10-22 | S, sale reported on Form 4 | 157,912 | $693.2K | 2024-10-22 |
| 2024-10-23 | S, sale reported on Form 4 | 16 | $70 | 2024-10-25 |
| 2024-10-24 | S, sale reported on Form 4 | 140,000 | $613.2K | 2024-10-25 |
| 2024-10-25 | S, sale reported on Form 4 | 4,800 | $21.0K | 2024-10-25 |
| 2024-11-01 | S, sale reported on Form 4 | 46,888 | $205.4K | 2024-11-05 |
| 2024-11-04 | S, sale reported on Form 4 | 94,144 | $413.3K | 2024-11-05 |
| 2024-11-11 | S, sale reported on Form 4 | 2,400 | $12.0K | 2024-11-13 |
| 2024-11-25 | S, sale reported on Form 4 | 1,600 | $8.0K | 2024-11-26 |
| 2024-11-27 | S, sale reported on Form 4 | 23,240 | $116.2K | 2024-12-02 |
| 2024-11-29 | S, sale reported on Form 4 | 98,888 | $495.4K | 2024-12-02 |
| 2024-12-02 | S, sale reported on Form 4 | 3,200 | $16.0K | 2024-12-02 |
| 2024-12-04 | S, sale reported on Form 4 | 67,608 | $338.0K | 2024-12-06 |
| 2024-12-05 | S, sale reported on Form 4 | 640,264 | $3.2M | 2024-12-06 |
| 2024-12-06 | S, sale reported on Form 4 | 162,800 | $815.6K | 2024-12-06 |
| 2025-04-29 | S, sale reported on Form 4 | 90,360 | $811.4K | 2025-05-01 |
| 2025-05-01 | S, sale reported on Form 4 | 78,736 | $704.7K | 2025-05-05 |
| 2025-05-01 | S, sale reported on Form 4 | 108,272 | $969.0K | 2025-05-05 |
| 2025-05-02 | S, sale reported on Form 4 | 400,000 | $3.6M | 2025-05-05 |
| 2025-05-27 | S, sale reported on Form 4 | 33,600 | $320.2K | 2025-05-29 |
| 2025-05-28 | S, sale reported on Form 4 | 157,704 | $1.5M | 2025-05-29 |
| 2025-05-29 | S, sale reported on Form 4 | 208,696 | $1.9M | 2025-05-29 |
| 2025-06-11 | S, sale reported on Form 4 | 400,000 | $4.6M | 2025-06-13 |
| 2025-08-01 | S, sale reported on Form 4 | 208,912 | $2.7M | 2025-08-05 |
SAB Biotherapeutics, Inc. (SABS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Vor Biopharma Inc. (VOR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1627642) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms